3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
7
Urinary Bladder Neoplasms
5
Lung Neoplasms
5
Glioma
5
Breast Neoplasms
5
Esophageal Neoplasms
4
Burkitt Lymphoma
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
3
Carcinoma
3
Sarcoma, Ewing
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Medulloblastoma
2
Laryngeal Neoplasms
2
Head and Neck Neoplasms
2
Gliosarcoma
2
Ganglioneuroblastoma
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Astrocytoma
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
Dexamethasone
2
Bortezomib
2
pomalidomide
1
isatuximab
1
fludarabine phosphate
1
elotuzumab
1
carfilzomib
1
belantamab mafodotin
1
Whole-Body Irradiation
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Lenalidomide
1
Fecal Microbiota Transplantation
1
Etoposide
1
Cyclosporine
1
Cyclophosphamide
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
Radiation
×
30 days
×
Clear all
No trials found.